SEC Form 4 · accession 0001628280-26-041330
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristen Williams
Officer — Chief Administrative Officer
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 5:57 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 3, 2026 | F | 8,528 | $22.32 | D | 177,321 | D | |
| Common StockF2 | Jun 4, 2026 | S | 10,259 | $22.27 | D | 167,062 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on September 10, 2025.